Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the U…
$241.55+0.49%
报价 2026-11-13
市值
$15.5B
EV
$15.24B
PE (TTM)
–
预期 PE
–
52 周区间距高点 -7.7%
$160.25$261.62
筛选结果
pipeline · 2026-11-13Filter✗ 高增长✗ Cheap✗ GARP
excluded industry: Biotechnology
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
同行业市值相近 · Biotechnology| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| JAZZJazz Pharmaceuticals plc | $15.5B | +0.5% | – | 88.2% | – | 109.6x | – | |
| BNTXBioNTech SE | $21.22B | +0.7% | – | 69% | – | – | 48.8x | |
| ASNDAscendis Pharma A/S | $18.06B | +3.1% | – | 86.3% | – | – | – | |
| EXELExelixis, Inc. | $17.34B | -1.2% | +10.1% | 96.4% | 14.4x | 11.5x | 15.1x | |
| BBIOBridgeBio Pharma, Inc. | $15.25B | +0.2% | +119.5% | 93.8% | – | – | – | |
| TECHBio-Techne Corporation | $11.44B | +0.1% | +5.4% | 65% | 99.6x | 43.2x | 37.1x | |
| HALOHalozyme Therapeutics, Inc. | $11.43B | -0.4% | +36.3% | 78.2% | 29.3x | 20.9x | 15.2x | |
| SMMTSummit Therapeutics Inc. | $11.29B | -6.1% | -94.2% | 0% | – | – | – | |
| BMRNBioMarin Pharmaceutical Inc. | $11.09B | +0.9% | +21.7% | 77.1% | 30.1x | 17.2x | 19.9x | |
| 同行中位数 | – | – | +15.9% | 77.7% | 29.7x | 19.0x | 19.9x |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据（首次研究运行后填充）。